BACKGROUND: There has been little rigorous economic analysis of the relationship between asthma and improved housing. AIM: To evaluate the cost-effectiveness of installing ventilation systems, and central heating if necessary, in homes of children with 'moderate' or 'severe' asthma. DESIGN AND SETTING: An incremental cost-effectiveness analysis alongside a pragmatic randomised controlled trial of a tailored package of housing modifications designed to improve ventilation and household heating in homes within Wrexham County Borough, Wales, UK. METHOD: A total of 177 children aged between 5 and 14 years, identified from general practice registers, were studied. Parents reported on the quality of life of their children over a 12-month period. General practices reported on health-service resources used by those children, and their asthma-related prescriptions, over the same period. RESULTS: The tailored package shifted 17% of children in the intervention group from 'severe' to 'moderate' asthma, compared with a 3% shift in the control group. The mean cost of these modifications was £1718 per child treated or £12300 per child shifted from 'severe' to 'moderate'. Healthcare costs over 12 months following randomisation did not differ significantly between intervention and control groups. Bootstrapping gave an incremental cost-effectiveness ratio (ICER) of £234 per point improvement on the 100-point PedsQL™ asthma-specific scale, with 95% confidence interval (CI) = £140 to £590. The ICER fell to £165 (95% CI = £84 to £424) for children with 'severe' asthma. CONCLUSION: This novel and pragmatic trial, with integrated economic evaluation, reported that tailored improvement of the housing of children with moderate to severe asthma is likely to be a cost-effective use of public resources. This is a rare example of evidence for collaboration between local government and the NHS.
RCT Entities:
BACKGROUND: There has been little rigorous economic analysis of the relationship between asthma and improved housing. AIM: To evaluate the cost-effectiveness of installing ventilation systems, and central heating if necessary, in homes of children with 'moderate' or 'severe' asthma. DESIGN AND SETTING: An incremental cost-effectiveness analysis alongside a pragmatic randomised controlled trial of a tailored package of housing modifications designed to improve ventilation and household heating in homes within Wrexham County Borough, Wales, UK. METHOD: A total of 177 children aged between 5 and 14 years, identified from general practice registers, were studied. Parents reported on the quality of life of their children over a 12-month period. General practices reported on health-service resources used by those children, and their asthma-related prescriptions, over the same period. RESULTS: The tailored package shifted 17% of children in the intervention group from 'severe' to 'moderate' asthma, compared with a 3% shift in the control group. The mean cost of these modifications was £1718 per child treated or £12300 per child shifted from 'severe' to 'moderate'. Healthcare costs over 12 months following randomisation did not differ significantly between intervention and control groups. Bootstrapping gave an incremental cost-effectiveness ratio (ICER) of £234 per point improvement on the 100-point PedsQL™ asthma-specific scale, with 95% confidence interval (CI) = £140 to £590. The ICER fell to £165 (95% CI = £84 to £424) for children with 'severe' asthma. CONCLUSION: This novel and pragmatic trial, with integrated economic evaluation, reported that tailored improvement of the housing of children with moderate to severe asthma is likely to be a cost-effective use of public resources. This is a rare example of evidence for collaboration between local government and the NHS.
Authors: Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed Journal: Value Health Date: 2005 Sep-Oct Impact factor: 5.725
Authors: G R Wright; S Howieson; C McSharry; A D McMahon; R Chaudhuri; J Thompson; I Donnelly; R G Brooks; A Lawson; L Jolly; L McAlpine; E M King; M D Chapman; S Wood; N C Thomson Journal: Allergy Date: 2009-07-24 Impact factor: 13.146
Authors: Helen Weatherly; Michael Drummond; Karl Claxton; Richard Cookson; Brian Ferguson; Christine Godfrey; Nigel Rice; Mark Sculpher; Amanda Sowden Journal: Health Policy Date: 2009-08-25 Impact factor: 2.980
Authors: Louise Woodfine; Richard D Neal; Nigel Bruce; Rhiannon T Edwards; Pat Linck; Linda Mullock; Nick Nelhans; Diana Pasterfield; Daphne Russell; Ian Russell Journal: Br J Gen Pract Date: 2011-11 Impact factor: 5.386
Authors: Bas Groot Koerkamp; M G Myriam Hunink; Theo Stijnen; James K Hammitt; Karen M Kuntz; Milton C Weinstein Journal: Med Decis Making Date: 2007 Mar-Apr Impact factor: 2.583
Authors: Philippa Howden-Chapman; Nevil Pierse; Sarah Nicholls; Julie Gillespie-Bennett; Helen Viggers; Malcolm Cunningham; Robyn Phipps; Mikael Boulic; Pär Fjällström; Sarah Free; Ralph Chapman; Bob Lloyd; Kristin Wickens; David Shields; Michael Baker; Chris Cunningham; Alistair Woodward; Chris Bullen; Julian Crane Journal: BMJ Date: 2008-09-23
Authors: Louise Woodfine; Richard D Neal; Nigel Bruce; Rhiannon T Edwards; Pat Linck; Linda Mullock; Nick Nelhans; Diana Pasterfield; Daphne Russell; Ian Russell Journal: Br J Gen Pract Date: 2011-11 Impact factor: 5.386
Authors: Lauren A Taylor; Annabel Xulin Tan; Caitlin E Coyle; Chima Ndumele; Erika Rogan; Maureen Canavan; Leslie A Curry; Elizabeth H Bradley Journal: PLoS One Date: 2016-08-17 Impact factor: 3.240
Authors: Janet Ige; Paul Pilkington; Judy Orme; Ben Williams; Emily Prestwood; D Black; Laurence Carmichael; Gabriel Scally Journal: J Public Health (Oxf) Date: 2019-06-01 Impact factor: 2.341
Authors: Koen F Tieskens; Chad W Milando; Lindsay J Underhill; Kimberly Vermeer; Jonathan I Levy; M Patricia Fabian Journal: Environ Health Date: 2021-02-14 Impact factor: 5.984
Authors: Amy Dymond; Stuart Mealing; Jessica McMaster; Hayden Holmes; Lesley Owen Journal: Int J Environ Res Public Health Date: 2021-02-09 Impact factor: 3.390
Authors: Angela Mary Tod; Peter Nelson; Anna Cronin de Chavez; Catherine Homer; Vanessa Powell-Hoyland; Amanda Stocks Journal: BMJ Open Date: 2016-01-06 Impact factor: 2.692